Skip to main content

Programme Category


Article available in the folowing languages:

Grant to the Coalition for Epidemic Preparedness Innovations (CEPI)

The Coalition for Epidemic Preparedness Innovations (CEPI) is an international non-profit association established under Norwegian Law. It was founded by the Governments of Norway, Germany, Japan, India, the Bill & Melinda Gates Foundation (BMGF) and the Wellcome Trust, and launched during the World Economic Forum in Davos 2017. Its objective is to finance and coordinate the development of new medical countermeasures to prevent and contain infectious disease epidemics, which are of particular concern to low-income countries. The H2020 funding will be used to enhance and expand CEPI's activities. This action will also contribute to the implementation of the Union’s strategy for international cooperation[[COM(2012)497]] in research and innovation and the EU’s development policy, in particular attention will be given to the constraints national health systems face in low and middle income countries.

This type of action differs from the ERA-NET Cofund and the EJP Cofund actions. Therefore, the conditions in General Annexes C and D, as well as the specific award criteria in General Annex H, do not apply.

In accordance with Article 9.3(c) of the Regulation (EU) 1290/2013 the minimum condition shall be the participation of one legal entity established in a Member State or associated country.

The main purpose of this action is to provide financial support to third parties through calls for proposals, in the forms of grants, in line with the following conditions in General Annex K[[Due to specific character of the action other conditions of General Annex K do not apply]]:

  • The proposal of the action must clearly detail the objectives and the results to be obtained and include at least the following elements:
  1. A fixed and exhaustive list of the different types of activities for which a third party may receive financial support;
  2. The definition of the persons or categories of persons which may receive financial support;
  3. The criteria for awarding financial support;
  4. The criteria for calculating the exact amount of the financial support;
  5. The maximum amount of financial support for each third party.
  • Additionally, the following conditions have to be fulfilled:
  1. The open calls must be published widely and must adhere to Horizon 2020 standards with respect to transparency, equal treatment, conflict of interest and confidentiality;
  2. All calls for third parties must be published on the Horizon 2020 Participants Portal and on the EU grant beneficiary’s own web site;
  3. The calls must remain open for at least two months; if call deadlines are changed this must immediately be published on the call page and all registered applicants must be informed of this change;
  4. Without delay, the outcome of the call must be published, including a description of the third party action, the date of the award, duration, and the legal name and country.
  • The beneficiary of the EU grant must ensure that the recipients of the financial support allow the Commission, the European Anti-fraud Office (OLAF) and the Court of Auditors to exercise their powers of control on documents, information, even stored on electronic media, or on the final recipient's premises.

The respective options of Articles 13.1 and 13.3 of the Mono Partner Model Specific Agreement will be applied.

In accordance with Article 23(7) of the Regulation No 1290/2013, Article 137(1)(c) of the Financial Regulation No 966/2012, Article 210a of the Rules of Application Regulation No 1268/2012, the maximum amount that can be paid to a third party may exceed EUR 60 000 (since this financial support is the primary aim of the action and necessary to achieve its objectives).

Eligible costs: Only the costs of providing financial support to third parties are eligible (if they comply with the general conditions and the specific conditions set out in the grant agreement) and the following categories of costs are not eligible:

  • Direct personnel costs;
  • Direct costs of subcontracting;
  • Other direct costs;
  • Indirect costs.

Funding rate: The EU contribution will be limited to a maximum of 70% of the total eligible costs of the action and it will take the form of a grant consisting of reimbursement of the eligible costs related to the action, in accordance with the conditions set out in the grant agreement.

Grant proposals will be evaluated by experts, on the basis of the award criteria ‘Excellence’, ‘Impact’ and ‘Quality and efficiency of the implementation’, in line with the Article 15 of the Horizon 2020 Rules for Participation Regulation No 1290/2013. In particular the following aspects will be taken into account:

  • Under the ""Excellence"" criterion:
  1. Clarity and pertinence of the objectives;
  2. Soundness of the concept, and credibility of the proposed methodology;
  3. Appropriate consideration of interdisciplinary approaches and, where relevant, use of stakeholder knowledge and gender dimension in research and innovation content;
  • Under the ""Impact"" criterion:

The extent to which the outputs of the action would contribute to each of the following expected impacts:

  1. To develop medical countermeasures against prioritised pathogens with epidemic potential;
  2. To help to prevent and contain epidemics;
  3. To support the Sustainable development goals 3.3[[]] “to combat communicable diseases"" and 3.B “to support the research and development of vaccines for the communicable diseases that primarily affect developing countries, and provide access to affordable essential vaccines”.

Quality of the proposed measures to:

  1. Exploit and disseminate the action results, and to manage research data where relevant;
  2. To communicate the action activities to different target audiences.
  • Under the ""Quality and efficiency of the implementation"" criterion:
  1. Quality and effectiveness of the work plan, including extent to which the resources assigned are in line with their objectives and deliverables;
  2. Appropriateness of the management structures and procedures, including risk and innovation management.

Model grant agreement: Mono-Partner Model Framework Partnership Agreement and Mono-Partner Model Specific Agreement

This grant will be awarded without call for proposals in line with Article 190(1)(e) of the Rules of applications of Regulation (EU, Euratom) 966/2012, Regulation No 1268/2012 and Article 11(2) of the Rules for participation and dissemination in ""Horizon 2020 - the Framework Programme for Research and Innovation (2014-2020)"", Regulation (EU) No 1290/2013